424 related articles for article (PubMed ID: 31052493)
41. Implications of
Chow YC; Yam HC; Gunasekaran B; Lai WY; Wo WY; Agarwal T; Ong YY; Cheong SL; Tan SA
Front Cell Infect Microbiol; 2022; 12():987683. PubMed ID: 36250046
[No Abstract] [Full Text] [Related]
42. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
43. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets.
Curran AM; Naik P; Giles JT; Darrah E
Nat Rev Rheumatol; 2020 Jun; 16(6):301-315. PubMed ID: 32341463
[TBL] [Abstract][Full Text] [Related]
44. The peptidylarginine deiminase gene is a conserved feature of Porphyromonas gingivalis.
Gabarrini G; de Smit M; Westra J; Brouwer E; Vissink A; Zhou K; Rossen JW; Stobernack T; van Dijl JM; van Winkelhoff AJ
Sci Rep; 2015 Sep; 5():13936. PubMed ID: 26403779
[TBL] [Abstract][Full Text] [Related]
45. Theoretical insights into the protonation states of active site cysteine and citrullination mechanism of Porphyromonas gingivalis peptidylarginine deiminase.
Zhao C; Ling B; Dong L; Liu Y
Proteins; 2017 Aug; 85(8):1518-1528. PubMed ID: 28486790
[TBL] [Abstract][Full Text] [Related]
46. Chemical biology of protein citrullination by the protein A arginine deiminases.
Mondal S; Thompson PR
Curr Opin Chem Biol; 2021 Aug; 63():19-27. PubMed ID: 33676233
[TBL] [Abstract][Full Text] [Related]
47. Novel furan-containing peptide-based inhibitors of protein arginine deiminase type IV (PAD4).
Teo CY; Tejo BA; Leow ATC; Salleh AB; Abdul Rahman MB
Chem Biol Drug Des; 2017 Dec; 90(6):1134-1146. PubMed ID: 28581157
[TBL] [Abstract][Full Text] [Related]
48. Peptidyl arginine deiminase inhibition suppresses arthritis via decreased protein citrullination in joints and serum with the downregulation of interleukin-6.
Kawaguchi H; Matsumoto I; Osada A; Kurata I; Ebe H; Tanaka Y; Inoue A; Umeda N; Kondo Y; Tsuboi H; Ishigami A; Sumida T
Mod Rheumatol; 2019 Nov; 29(6):964-969. PubMed ID: 30285515
[No Abstract] [Full Text] [Related]
49. The link between periodontal disease and rheumatoid arthritis: an updated review.
Koziel J; Mydel P; Potempa J
Curr Rheumatol Rep; 2014 Mar; 16(3):408. PubMed ID: 24458478
[TBL] [Abstract][Full Text] [Related]
50. GnRH Stimulates Peptidylarginine Deiminase Catalyzed Histone Citrullination in Gonadotrope Cells.
Khan SA; Edwards BS; Muth A; Thompson PR; Cherrington BD; Navratil AM
Mol Endocrinol; 2016 Oct; 30(10):1081-1091. PubMed ID: 27603413
[TBL] [Abstract][Full Text] [Related]
51. The Development of Benzimidazole-Based Clickable Probes for the Efficient Labeling of Cellular Protein Arginine Deiminases (PADs).
Nemmara VV; Subramanian V; Muth A; Mondal S; Salinger AJ; Maurais AJ; Tilvawala R; Weerapana E; Thompson PR
ACS Chem Biol; 2018 Mar; 13(3):712-722. PubMed ID: 29341591
[TBL] [Abstract][Full Text] [Related]
52. An interplay of structure and intrinsic disorder in the functionality of peptidylarginine deiminases, a family of key autoimmunity-related enzymes.
Alghamdi M; Al Ghamdi KA; Khan RH; Uversky VN; Redwan EM
Cell Mol Life Sci; 2019 Dec; 76(23):4635-4662. PubMed ID: 31342121
[TBL] [Abstract][Full Text] [Related]
53. Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis.
Reyes-Castillo Z; Muñoz-Valle JF; Llamas-Covarrubias MA
Autoimmun Rev; 2018 Feb; 17(2):94-102. PubMed ID: 29196243
[TBL] [Abstract][Full Text] [Related]
54. Current knowledge into the role of the peptidylarginine deiminase (PAD) enzyme family in cardiovascular disease.
Al-U'datt DGF; Allen BG; Hiram R; Alrabadi N
Eur J Pharmacol; 2021 Jan; 891():173765. PubMed ID: 33249073
[TBL] [Abstract][Full Text] [Related]
55. The association between rheumatoid arthritis and periodontitis.
Leech MT; Bartold PM
Best Pract Res Clin Rheumatol; 2015 Apr; 29(2):189-201. PubMed ID: 26362738
[TBL] [Abstract][Full Text] [Related]
56. Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis.
Demoruelle MK; Wang H; Davis RL; Visser A; Hoang J; Norris JM; Holers VM; Deane KD; Darrah E
Arthritis Res Ther; 2021 Jun; 23(1):163. PubMed ID: 34092252
[TBL] [Abstract][Full Text] [Related]
57. Peptidyl arginine deiminase 4 and its potential role in Alzheimer's disease.
Wang LL; Song YP; Mi JH; Ding ML
Med Hypotheses; 2021 Jan; 146():110466. PubMed ID: 33412502
[TBL] [Abstract][Full Text] [Related]
58. Thioredoxin Modulates Protein Arginine Deiminase 4 (PAD4)-Catalyzed Citrullination.
Nagar M; Tilvawala R; Thompson PR
Front Immunol; 2019; 10():244. PubMed ID: 30853960
[TBL] [Abstract][Full Text] [Related]
59. Identification of a new genetic variant (G231N, E232T, N235D) of peptidylarginine deiminase from
Bereta GP; Strzelec K; Łazarz-Bartyzel K; Dziedzic-Kowalska A; Nowakowska Z; Krutyhołowa A; Bielecka E; Kantyka T; Grabiec AM; Kaczmarzyk T; Chomyszyn-Gajewska M; Potempa J; Gawron K
Front Immunol; 2024; 15():1355357. PubMed ID: 38576615
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.
Jones JE; Slack JL; Fang P; Zhang X; Subramanian V; Causey CP; Coonrod SA; Guo M; Thompson PR
ACS Chem Biol; 2012 Jan; 7(1):160-5. PubMed ID: 22004374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
